Latest AI and machine learning research in other cancers for healthcare professionals.
Malignant tumors, including osteosarcoma (OS), are major non-communicable chronic diseases driven by...
RATIONALE AND OBJECTIVE: Anaplastic thyroid carcinoma (ATC) may arise from the progression of differ...
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with a five-year survival ...
Neoantigens are critical targets for cancer immunotherapy, yet the relationship between experimental...
Transarterial chemoembolization (TACE) is a cornerstone locoregional therapy for hepatocellular carc...
The dynamics of tumor-immune interactions within a complex tumor microenvironment are typically mode...
BACKGROUND: Nasopharyngeal carcinoma (NPC) represents a highly prevalent and aggressive malignancy e...
Oral squamous cell carcinoma (OSCC) is often preceded by oral potentially malignant disorders (OPMDs...
BACKGROUND: Skin cancer is one of the most prevalent malignancies worldwide, particularly within Cau...
OBJECTIVES: Early detection and resection of colorectal polyps prevent their progression toward adva...
In recent years, the field of medical imaging has witnessed substantial progress due to the integrat...
OBJECTIVES: Accurate prediction of axillary lymph node metastasis (ALNM) is crucial for tailoring br...
BACKGROUND: Disulfidptosis is a novel form of glucose starvation-induced cell death, yet its prognos...
PURPOSE: The ENZAMET trial established that enzalutamide added to androgen deprivation therapy (ADT)...
Prostate cancer (PCa) is one of the most prevalent malignancies in men worldwide, and metabolic repr...
Lung carcinoma is regarded as lung cancer and is the usual form of cancers worldwide. It cannot be d...
Triple-negative breast cancer (TNBC) patients often ential hypertension, yet how systemic vascular s...
The urgent need for innovative cancer therapies has driven increasing interest in repurposing drugs ...
PURPOSE: Non-small cell lung cancer (NSCLC) remains a major clinical challenge, with Programmed deat...
BACKGROUND: Mutations in CTNNB1 are recognized oncogenic drivers of hepatocellular carcinoma (HCC); ...
The field of oncology has witnessed remarkable progress with the integration of high-tech innovation...